Rare Occurrence of Apical Hypertrophic Cardiomyopathy Among Hispanics

Mohammed S Abdalla1, Prasun Pudasainee1, Akshaya Ramachandran1

  • 1Department of Internal Medicine, Ascension Saint Francis Hospital, Evanston, IL, USA.

Cardiology Research
|January 20, 2023
PubMed

Insights

Apical hypertrophic cardiomyopathy (ApHCM), a rare variant of hypertrophic cardiomyopathy, was diagnosed in a Hispanic male. This case highlights ApHCM

Area of Science:

  • Cardiology
  • Genetics

Background:

  • Apical hypertrophic cardiomyopathy (ApHCM), or Yamaguchi syndrome, is a rare variant of hypertrophic cardiomyopathy (HCM).
  • Characterized by predominant hypertrophy of the left ventricular apex.
  • Typically presents with distinct ECG and imaging findings.

Observation:

  • A 66-year-old Hispanic male with a history of atrial fibrillation, NSTEMI, and cardiac arrest was diagnosed with ApHCM.
  • This case represents a rare occurrence of ApHCM in the Hispanic population.
  • The patient exhibited extreme clinical features, including ventricular arrhythmias and cardiac arrest.

Findings:

  • ApHCM diagnosis in a Hispanic male, challenging the notion of its rarity in non-Asian populations.
  • The patient's presentation mimicked ischemic coronary heart disease, underscoring diagnostic challenges.
  • Unusual severe clinical course with ventricular arrhythmias and cardiac arrest, deviating from the typical benign natural history.

Implications:

  • Highlights the need for a high index of suspicion for ApHCM in patients with cardiac symptoms, even in non-Asian populations.
  • Suggests ApHCM can present with severe, life-threatening arrhythmias, contrary to its usual benign course.
  • Emphasizes the importance of considering ApHCM in differential diagnoses of unexplained cardiac events and hypertrophy.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
29
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
36
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
17
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
23
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
23